Phenominer Database Results (20 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
SD heart left ventricle end-systolic diameter sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.8 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98853 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98854 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.0 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98855 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.1 mm 0.2 0.45 echocardiography 0.0 sham ACF 2 days 99349 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98852 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98850 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.0 mm 0.2 0.45 echocardiography 0.0 ACF 2 days 99350 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 5.9 mm 0.2 0.57 echocardiography 0.0 ACF 28 days 99354 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.8 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99352 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98856 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.3 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99240 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 4.3 mm 0.3 0.85 echocardiography 0.0 sham ACF 28 days 99239 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 7 4.7 mm 0.2 0.53 echocardiography 0.0 sham ACF 28 days 99353 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.2 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98851 2160
SD heart left ventricle end-systolic diameter sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 175 days 10 5.6 mm 0.1 0.32 echocardiography 0.0 sham ACF 105 days 99241 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 7 4.7 mm 0.2 0.53 echocardiography 0.0 sham ACF 28 days 99351 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.9 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98857 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 175 days 10 7.4 mm 0.3 0.95 echocardiography 0.0 ACF 105 days 99242 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.3 mm 0.5 1.12 echocardiography 0.0 ACF 2 days 99348 2278
SD heart left ventricle end-systolic diameter sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.0 mm 0.2 0.45 echocardiography 0.0 sham ACF 2 days 99347 2278